과제정보
The above study was financially supported by the National Natural Science Foundation of China (82074131, 81774170), the Natural Science Foundation of Guangdong Province (2018B030306012), Guangzhou Basic and Applied Basic Research Project (202201011800), the Outstanding Youth Development Scheme project of Southern Medical University (G621299870), Young Elite Scientists Sponsorship Program by CACM (2021-QNRC2-B28).
참고문헌
- Piche ME, Tchernof A, Despres JP. Obesity phenotypes, diabetes, and cardiovascular diseases. CIRC RES 2020;126(11):1477-500. https://doi.org/10.1161/CIRCRESAHA.120.316101
- Kolotkin RL, Meter K, Williams GR. Quality of life and obesity. OBES REV 2001;2(4):219-29. https://doi.org/10.1046/j.1467-789X.2001.00040.x
- Wang C, Chan JS, Ren L, Yan JH. Obesity reduces cognitive and motor functions across the lifespan. NEURAL PLAST 2016;2016:2473081.
- Peters U, Dixon AE, Forno E. Obesity and asthma. J Allergy Clin Immunol 2018;141(4):1169-79. https://doi.org/10.1016/j.jaci.2018.02.004
- Vecchie A, Dallegri F, Carbone F, Bonaventura A, Liberale L, Portincasa P, Fruhbeck G, Montecucco F. Obesity phenotypes and their paradoxical association with cardiovascular diseases. EUR J INTERN MED 2018;48:6-17. https://doi.org/10.1016/j.ejim.2017.10.020
- Seravalle G, Grassi G. Obesity and hypertension. PHARMACOL RES 2017;122: 1-7. https://doi.org/10.1016/j.phrs.2017.05.013
- Freedman RA, Partridge AH. Emerging data and current challenges for Young, old, obese, or male patients with breast cancer. CLIN CANCER RES 2017;23(11):2647-54. https://doi.org/10.1158/1078-0432.CCR-16-2552
- Baker KD, Loughman A, Spencer SJ, Reichelt AC. The impact of obesity and hypercaloric diet consumption on anxiety and emotional behavior across the lifespan. Neurosci Biobehav Rev 2017;83:173-82. https://doi.org/10.1016/j.neubiorev.2017.10.014
- German NJ, Yoon H, Yusuf RZ, Murphy JP, Finley LW, Laurent G, Haas W, Satterstrom FK, Guarnerio J, Zaganjor E, et al. PHD3 loss in cancer enables metabolic reliance on fatty acid oxidation via deactivation of ACC2. MOL CELL 2016;63(6):1006-20. https://doi.org/10.1016/j.molcel.2016.08.014
- Irshad Z, Dimitri F, Christian M, Zammit VA. Diacylglycerol acyltransferase 2 links glucose utilization to fatty acid oxidation in the brown adipocytes. J LIPID RES 2017;58(1):15-30. https://doi.org/10.1194/jlr.M068197
- Taib B, Aboussalah AM, Moniruzzaman M, Chen S, Haughey NJ, Kim SF, Ahima RS. Lipid accumulation and oxidation in glioblastoma multiforme. Sci Rep 2019;9(1):19593.
- Campisi J, Kapahi P, Lithgow GJ, Melov S, Newman JC, Verdin E. From discoveries in ageing research to therapeutics for healthy ageing. NATURE 2019;571(7764):183-92. https://doi.org/10.1038/s41586-019-1365-2
- Liu Q, Zhang FG, Zhang WS, Pan A, Yang YL, Liu JF, Li P, Liu BL, Qi LW. Ginsenoside Rg1 inhibits glucagon-induced hepatic gluconeogenesis through akt-FoxO1 interaction. THERANOSTICS 2017;7(16):4001-12. https://doi.org/10.7150/thno.18788
- Alolga RN, Nuer-Allornuvor GF, Kuugbee ED, Yin X, Ma G. Ginsenoside Rg1 and the control of inflammation implications for the therapy of type 2 diabetes: a review of scientific findings and call for further research. PHARMACOL RES 2020;152:104630.
- Bai L, Gao J, Wei F, Zhao J, Wang D, Wei J. Therapeutic potential of ginsenosides as an adjuvant treatment for diabetes. FRONT PHARMACOL 2018;9:423.
- Gao Y, Chu S, Zhang Z, Chen N. Hepataprotective effects of ginsenoside Rg1 - a review. J ETHNOPHARMACOL 2017;206:178-83. https://doi.org/10.1016/j.jep.2017.04.012
- Gao Y, Li J, Wang J, Li X, Li J, Chu S, Li L, Chen N, Zhang L. Ginsenoside Rg1 prevent and treat inflammatory diseases: a review. INT IMMUNOPHARMACOL 2020;87:106805.
- Xu X, Qu Z, Qian H, Li Z, Sun X, Zhao X, Li H. Ginsenoside Rg1 ameliorates reproductive function injury in C57BL/6J mice induced by di-N-butyl-phthalate. ENVIRON TOXICOL 2021;36(5):789-99. https://doi.org/10.1002/tox.23081
- Shen CY, Jiang JG, Yang L, Wang DW, Zhu W. Anti-ageing active ingredients from herbs and nutraceuticals used in traditional Chinese medicine: pharmacological mechanisms and implications for drug discovery. Br J Pharmacol 2017;174(11):1395-425. https://doi.org/10.1111/bph.13631
- Song L, Xu MB, Zhou XL, Zhang DP, Zhang SL, Zheng GQ. A preclinical systematic review of ginsenoside-rg1 in experimental Parkinson's disease. OXID MED CELL LONGEV 2017;2017:2163053.
- Yu X, Li H, Lin D, Guo W, Xu Z, Wang L, Guan S. Ginsenoside prolongs the lifespan of C. elegans via lipid metabolism and activating the stress response signaling pathway. INT J MOL SCI 2021;22(18).
- Li S, Xu S, Ma Y, Wu S, Feng Y, Cui Q, Chen L, Zhou S, Kong Y, Zhang X, et al. A genetic screen for mutants with supersized lipid droplets in Caenorhabditis elegans. G3 (Bethesda) 2016;6(8):2407-19. https://doi.org/10.1534/g3.116.030866
- Watts JL, Ristow M. Lipid and carbohydrate metabolism in Caenorhabditis elegans. GENETICS 2017;207(2):413-46.
- Prodromou C. Mechanisms of Hsp90 regulation. BIOCHEM J 2016;473(16):2439-52. https://doi.org/10.1042/BCJ20160005
- Chen Y, Zhou X. Research progress of mTOR inhibitors. EUR J MED CHEM 2020;208:112820.
- Yuan X, Lu H, Zhao A, Ding Y, Min Q, Wang R. Transcriptional regulation of CYP3A4 by nuclear receptors in human hepatocytes under hypoxia. DRUG METAB REV 2020;52(2):225-34. https://doi.org/10.1080/03602532.2020.1733004
- Han D, Jiang L, Gu X, Huang S, Pang J, Wu Y, Yin J, Wang J. SIRT3 deficiency is resistant to autophagy-dependent ferroptosis by inhibiting the AMPK/mTOR pathway and promoting GPX4 levels. J CELL PHYSIOL 2020;235(11):8839-51. https://doi.org/10.1002/jcp.29727
- Geng Z, Fan WY, Zhou B, Ye C, Tong Y, Zhou YB, Xiong XQ. FNDC5 attenuates obesity-induced cardiac hypertrophy by inactivating JAK2/STAT3-associated inflammation and oxidative stress. J TRANSL MED 2019;17(1):107.
- Galikova M, Klepsatel P. Obesity and aging in the Drosophila model. INT J MOL SCI 2018;19(7).
- Partridge L, Deelen J, Slagboom PE. Facing up to the global challenges of ageing. NATURE 2018;561(7721):45-56. https://doi.org/10.1038/s41586-018-0457-8
- Pifferi F, Aujard F. Caloric restriction, longevity and aging: recent contributions from human and non-human primate studies. Prog Neuropsychopharmacol Biol Psychiatry 2019;95:109702.
- Caballero B. Humans against obesity: who will win? ADV NUTR 2019;10(suppl_1):S4-9. https://doi.org/10.1093/advances/nmy055
- Obesity and overweight. World Health Organization; 2020.
- Bales CW, Porter SK. Obesity interventions for older adults: diet as a determinant of physical function. ADV NUTR 2018;9(2):151-9. https://doi.org/10.1093/advances/nmx016
- Maclean PS, Bergouignan A, Cornier MA, Jackman MR. Biology's response to dieting: the impetus for weight regain. Am J Physiol Regul Integr Comp Physiol 2011;301(3):R581-600. https://doi.org/10.1152/ajpregu.00755.2010
- Kiefer D, Pantuso T. Panax ginseng. AM FAM PHYSICIAN 2003;68(8):1539-42.
- Yin X, Hu H, Shen X, Li X, Pei J, Xu J. Ginseng omics for ginsenoside biosynthesis. Curr Pharm Biotechnol 2021;22(5):570-8. https://doi.org/10.2174/1389201021666200807113723
- Liu Q, Zhang FG, Zhang WS, Pan A, Yang YL, Liu JF, Li P, Liu BL, Qi LW. Ginsenoside Rg1 inhibits glucagon-induced hepatic gluconeogenesis through akt-FoxO1 interaction. THERANOSTICS 2017;7(16):4001-12. https://doi.org/10.7150/thno.18788
- Gao Y, Chu S, Zhang Z, Chen N. Hepataprotective effects of ginsenoside Rg1 - a review. J ETHNOPHARMACOL 2017;206:178-83. https://doi.org/10.1016/j.jep.2017.04.012
- Vatner SF, Zhang J, Oydanich M, Berkman T, Naftalovich R, Vatner DE. Healthful aging mediated by inhibition of oxidative stress. AGEING RES REV 2020;64:101194.
- Hao S, Chao Z, Jiamin Z, Yiwen L, Yunjia L, Junjie L, Zhiyun Z, Lei G. Cold stress reduces lifespan and mobility of C. elegans by mediating lipid metabolism disorder and abnormal stress response. Journal of Southern Medical University 2022;42(8):1159-65.